+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Loestrin 24 Fe - API Insight, 2022

  • PDF Icon

    Drug Pipelines

  • 30 Pages
  • January 2022
  • Region: Global
  • DelveInsight
  • ID: 4038593
UP TO OFF until Dec 31st 2024
"Loestrin 24 Fe - API 2022" report by the publisher provides product and API manufacturers details across US, Europe, China and India for Loestrin 24 Fe . It includes Loestrin 24 Fe overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Loestrin 24 Fe's patents information (US & EU). It also features the historical and forecasted sales of Loestrin 24 Fe 2024. The report also highlights Loestrin 24 Fe's market competition and emerging therapies which are in the same space as Loestrin 24 Fe

Methodology


Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the Report


A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
Patent information around Loestrin 24 Fe in United States (US) and Europe (EU) has been highlighted
API manufacturers for Loestrin 24 Fe in United States, Europe, China and India
The report contains historical and forecasted sales for Loestrin 24 Fe 2024
Enlists the market competition and emerging therapies in the space where Loestrin 24 Fe operates

Reasons to Buy


Establish a comprehensive understanding of the drug, Loestrin 24 Fe
Access to Loestrin 24 Fe's API manufacturers details to devise API procurement strategy for generic development
Plan generic developmental timelines around Loestrin 24 Fe's patents for the major markets- US and EU
Understand Loestrin 24 Fe's current and future growth through its historical and forecasted sales
Identify the current in-market competitors for Loestrin 24 Fe
Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
Identify the emerging players and their products operating in the same space as Loestrin 24 Fe.

Table of Contents

1. Report Introduction
2. Loestrin 24 Fe Overview
  • Product Description
  • Mechanism of Action
  • Dosage and Administration
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties
  • Safety and Efficacy of Loestrin 24 Fe
  • Clinical Trial Description
  • Adverse Reactions
  • Product Development Activities

3. Product Details
  • United States
  • Europe

4. Loestrin 24 Fe Global Sales Assessment
  • Historical Global Sales
  • Forecasted Global Sales

5. Patent Details
6. Global API Manufacturers Assessment
  • United States
  • Europe
  • China
  • India

7. Market Competitors8. Emerging Therapies
9. Appendix
  • Methodology
  • Consulting Services
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
Table 1: Loestrin 24 Fe Description
Table 2: Loestrin 24 Fe Product Details, United States
Table 3: Loestrin 24 Fe Product Details, Europe
Table 4: Loestrin 24 Fe , Historical Global Sales till 2021 (in million USD)
Table 5: Loestrin 24 Fe , Forecasted Global Sales from 2022-2024 (in million USD)
Table 6: Patent Details: Loestrin 24 Fe
Table 7: API Manufacturers Region wise
Table 8: API Manufacturers for United States
Table 9: API Manufacturers for Europe
Table 10: API Manufacturers for China
Table 11: API Manufacturers for India
Table 12: Loestrin 24 Fe Market Competitors
Table 13: Emerging Therapies
List of Figures
Figure 1: Loestrin 24 Fe
Figure 2: Loestrin 24 Fe , Historical Global Sales till 2017 (in million USD)
Figure 3: Loestrin 24 Fe , Forecasted Global Sales from 2020-2022 (in million USD)
Figure 4: Patent Details: Loestrin 24 Fe
Figure 5: API Manufacturers Region wise
Figure 6: Patent Details: Loestrin 24 Fe
Figure 7: API Manufacturers Region wise
Figure 8: API Manufacturers for United States
Figure 9: API Manufacturers for Europe
Figure 10: API Manufacturers for China
Figure 11: API Manufacturers for India
Figure 12: Loestrin 24 Fe Market Competitors
Figure 13: Emerging Therapies